X

The Difference in Guanfacine Formulations for ADHD

By: Katharine Cimmino, Editor-in-Chief - Attention-deficit/hyperactivity disorder (ADHD) is the most common pediatric psychiatric disorder, and it affects the education,…

eMAR

Using Bacteriophage Enzymes to Stay One Step Ahead of MRSA

By: Davidta Brown, Copy Editor [Content-Focused] - It’s difficult to have a discussion about antibiotics without mentioning the developing crisis…

eMAR

Interview: Med Ed 101: Dr. Eric Christianson

By: Tasnima Nabi, Copy Editor [Content-Focused] - Social media is a powerful platform, allowing for the quick and easy exchange…

eMAR

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

eMAR

FDA Defends Generic Drug Labeling Plan

By: Nancy Simon, PharmD c/o 2016 - Last November, the Food and Drug Administration (FDA) submitted a proposal for a…

eMAR

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

eMAR

Interested in joining the Rho Chi Post?

Submit an article and letter of intent To rhochipost@gmail.com View the application: http://rhochistj.org/RhoChiPost/application/ Below are some FAQ; please email us…

eMAR

Meet the Air Force: Dr. Joanne Bollhofer-White

By: Melissa Roy Co-Copy Editor [Graphics focused] -- Many people do not realize the opportunities that are available to pharmacists.…

eMAR

The Silver Age of Antibiotics

By: Andrew Leong, Staff Writer -- This year, the FDA approved three new antibiotics to treat acute bacterial skin and…

eMAR

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

eMAR